The present application is a national stage entry of PCT Application No. PCT/GB2007/000287, filed Jan. 29, 2007, which claims priority to Great Britain application GB 0601712.3, filed Jan. 27, 2006, the disclosures of which are hereby incorporated by reference in their entireties.
The present invention relates to an insect-repellent fabric.
In order to render a fabric insect-repellent, one method, particularly adopted by the military, is to soak combat clothing in an insecticide, such as permethrin. However, this tends to make the garments uncomfortable and causes an unpleasant odor. Also, it has a limited period of effectiveness. It is also known to impregnate the heel and toe portions of socks with a scented material and to impregnate socks and certain sports clothing with natural remedies, such as Aloe Vera extract.
Currently, mosquitoes are one of the greatest causes of death in humans. One in 17 people alive today will be killed by mosquito bites. Worldwide, over 700 million people are infected by mosquitoes each year, with over 3 million dying. In the United Kingdom, biting insects can generally spoil holidays and can be a serious concern for parents with sensitive or allergic children.
It is an object of the invention to provide a textile article which is effective in repelling biting insects and which has a long lasting effect. It is a further object to provide a delivery mechanism which eliminates the need for sticky and malodorous, directly applied chemicals, which tend to be neither safe nor particularly effective. It is a further object to provide a safe and hypoallergenic inset repellent for children.
According to an embodiment the invention, an insect-repellent fabric comprises a fabric base and an active insect repellent ingredient, in which the active ingredient is contained within micro-capsules, and the fabric base is impregnated with the micro-capsules.
The microcapsules can be in the size range of about 1 μm to about 7 μm, and more about 2 μm to about 4 μm, and can have a mean diameter of about 3 μm.
In one embodiment of the invention, the fabric base is knitted (weft or warp), woven or spun-bonded from a spun yarn made from non-continuous short filaments and/or yarn made from continuous filaments. The material can be selected from polyester, nylon, cotton, or any suitable material and combinations thereof.
The fabric base is subjected to binding and finishing. The binding process can selectively bind the micro-capsules to the fibres and can comprise heating to a temperature in a range of about 40° C. to about 160° C., particularly of about 80° C. to about 120° C., for a period of at least 20 seconds, however, the precise parameters can be determined by the particular process and machinery being used. The binding process can be an ion-exchange process, for example.
The active ingredient can be selected from an extract of Citronella and DEET. One example material is para-menthane-3,8-diol; conveniently, this is isolated from a natural source (lemon eucalyptus oil), and then added to a non-reactive base oil. During this synthesis process, the plant extracts Limonene and Linalool, which are known sensitizers, are removed. The invention also extends to the example composition per se and in its encapsulated form.
The impregnated fabric is then cut to size for use in clothing manufacture or for use as an impregnated cloth for topical application of the micro-capsules. Alternatively, the fabric can be formed into a finished article first and then impregnated.
The invention provides a unique chemical repelling agent which provides a comparative level of efficacy to military specification DEET products. It also provides a chemical repelling agent specifically designed to eliminate or reduce allergens and sensitizers to ensure hypoallergenicity and safety for children. The delivery system of a microencapsulated active agent bound to a fabric at a molecular level, ensures effectiveness, consistency and durability.
Fragrance can also be incorporated, either in the same microcapsules as the active ingredient or in separate microcapsules.
The detection of the fragrance in use can serve as an indicator that the active ingredient is still present and effective.
The invention may be carried into practice in various ways and some specific embodiments will now be described by way of example.
A fabric is first prepared by knitting from non-continuous short filament synthetic spun yarn. While microencapsulated chemicals can be bound to other fibers, this has been found to be the most efficacious. This fabric is then sent to a binding shop for dying and micro-encapsulation.
The binding process uses an ionic based process to selectively bind the micro-capsules to the fabric. The process heats the ends of the fiber filaments to a point where they ‘open’ (like a flower). An ion-exchange process then drives the encapsulated active component into the open fabric pore, which then closes around it, binding it in place.
The active ingredient or component is para-menthane-3,8-diol. It is a modified natural extract of Eucalyptus Maculata Citriodora. It is dissolved in isopropyl myristate and subjected to a micro-encapsulation process, using a Melamine based polymer in an aqueous solution at a mean micron size of about 3. The resultant product is then combined with a soft acrylic binder in anionic form and applied to the fabric base by means of a paddling mangle, and is then dried at about 140° C. The application can also be made via an exhaust process using a non-ionic soft acrylic binder or a spraying or foaming process using a soft acrylic binder in anionic form.
Number | Date | Country | Kind |
---|---|---|---|
0601712.3 | Jan 2006 | GB | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/GB2007/000287 | 1/29/2007 | WO | 00 | 11/26/2008 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2007/085856 | 8/2/2007 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
20020039593 | Tucci et al. | Apr 2002 | A1 |
20060188582 | Naylor Da Rocha Gomes | Aug 2006 | A1 |
Number | Date | Country |
---|---|---|
2675247 | Aug 2008 | CA |
0 348 550 | Jan 1990 | EP |
2 811 864 | Jan 2002 | FR |
2 858 637 | Feb 2005 | FR |
2 385 789 | Sep 2003 | GB |
2 434 592 | Jun 2009 | GB |
3-2101 | Jan 1991 | JP |
3-148203 | Jun 1991 | JP |
4352703 | Dec 1992 | JP |
5-132402 | May 1993 | JP |
2000-328463 | Nov 2000 | JP |
20020091968 | Dec 2002 | KR |
WO 9517091 | Jun 1995 | WO |
WO 9823149 | Jun 1998 | WO |
WO 2005018795 | Mar 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20090081267 A1 | Mar 2009 | US |